Cargando…
Ceftazidime-avibactam
The increase in nosocomial infections by beta-lactamase-producing Gram-negative bacilli constitutes a therapeutic challenge. The combination of ceftazidime-avibactam offers a very interesting therapeutic option for nosocomial pneumonia caused by extended-spectrum beta-lactamase-producing Klebsiella...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedad Española de Quimioterapia
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106208/ https://www.ncbi.nlm.nih.gov/pubmed/35488824 http://dx.doi.org/10.37201/req/s01.09.2022 |